InFlaMed Inc is focused on serving the millions around the world from all socioeconomic classes who are genetically predisposed to Alzheimer's Disease and are likely to experience memory loss with age

Alzheimer's Disease(AD) is a major cause of dementia among the aging population all over the world. While there is some hope for persons from western countries, from the recently FDA approved treatments for those with mild cognitive deficit there is currently no hope especially in the economically challenged countries for millions across the world who are genetically predisposed to AD. One major factor that contributes to AD is compliment mediated neuroinflammation which progresses to early memo...

Alzheimer's Disease(AD) is a major cause of dementia among the aging population all over the world. While there is some hope for persons from western countries, from the recently FDA approved treatments for those with mild cognitive deficit there is currently no hope especially in the economically challenged countries for millions across the world who are genetically predisposed to AD. One major factor that contributes to AD is compliment mediated neuroinflammation which progresses to early memory loss accompanied with aging. InFlaMed Inc has developed an affordable product that can be self administered and could be available over the counter in a pharmacy anywhere in the world. The product will protect memory from neuroinflammation and will save those who have anxiety about being unable to take care of themselves independently of costly care givers. In addition to those who are genetically predisposed to AD, those who have had traumatic brain injury could also slow progression to AD.